Venetoclax Plus Chemotherapy Enables Stem Cell Transplant in Refractory Lymphoma Case
Clinicians in Turkey report that adding venetoclax to ICE chemotherapy enabled a 21-year-old man with chemorefractory hepatosplenic T-cell lymphoma to ...
Clinicians in Turkey report that adding venetoclax to ICE chemotherapy enabled a 21-year-old man with chemorefractory hepatosplenic T-cell lymphoma to ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.